Marca Nominativa depositada no INPI em 08/12/2023 por REGENXBIO Inc., processo nº 501771424, nas classes 05. Registro em vigor até 08/12/2033.
| Número do processo | 501771424 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 08/12/2023 |
| Data da concessão | 23/12/2025 |
| Vigência até | 08/12/2033 |
| Titular | REGENXBIO Inc. |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Biological preparations for medical use; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations for use in gene therapy; clinical medical reagents for use in gene therapy; pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, lysosomal storage disorders; gene therapy preparation containing genetic materials for sustained protein expression, namely, lysosomal enzyme expression.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501771424 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.